TSS
SGMO

Two Sigma Securities’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Two Sigma Securities’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,300
Closed -$223K – 1623
2020
Q4 		$223K Buy
+14,300
New +$168K 0.01% 1305

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Two Sigma Securities's SGMO Position: Q1 2026 in Review

Two Sigma Securities increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 241% in Q1 2026, buying an estimated $16.9K and bringing the position to 60,102 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Two Sigma Securities first reported a position in SGMO in Q4 2016 and has held it in 6 quarters since. The position peaked at $177K in Q2 2019. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Two Sigma Securities held 60,102 shares of SANGAMO THERAPEUTICS INC worth $14.8K as of Q1 2026.
  • Two Sigma Securities bought 42,480 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $16.9K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1422 holding.
  • Two Sigma Securities first reported a position in SANGAMO THERAPEUTICS INC in Q4 2016 and has held it in 6 quarters since.
  • Two Sigma Securities's SANGAMO THERAPEUTICS INC position peaked at $177K in Q2 2019.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.